Fagron’s API Facility in Minnesota Gets FDA Warning Letter

By PacConAdmin | June 30, 2022

Netherlands-based Fagron drew a warning letter from the FDA for its facility in St. Paul, Minn., for inadequate equipment cleaning that could lead to cross-contamination of its drug products.
Source: Drug Industry Daily

Posted in Drug Industry Daily